| Antiviral | EC50 ratio | Phenotype | Strain | Source | Marker | Assay | Reference |
|---|---|---|---|---|---|---|---|
| Cidofovir | 0.90 | No resistance | Laboratory strain, Clinical Isolate | Details | Drug Resistance Mutations and Associated Phenotypes Detected in Clinical Trials of Maribavir for Treatment of Cytomegalovirus Infection. (Sep 2022) | ||
| Foscarnet | 3.10 | Intermediate level resistance | Laboratory strain, Clinical Isolate | Details | Drug Resistance Mutations and Associated Phenotypes Detected in Clinical Trials of Maribavir for Treatment of Cytomegalovirus Infection. (Sep 2022) | ||
| Ganciclovir | 0.90 | No resistance | Laboratory strain, Clinical Isolate | Details | Drug Resistance Mutations and Associated Phenotypes Detected in Clinical Trials of Maribavir for Treatment of Cytomegalovirus Infection. (Sep 2022) |
| Mutant | Resistances |
|---|---|
| A987G |
Ganciclovir:
|
| A987G |
Cidofovir:
|
| A987G |
Foscarnet:
|
| A987G |
Cidofovir:
|
| A987G |
Cidofovir:
|